Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01190488 · ClinicalTrials.gov registry record · NA

Feasibility Of An Advanced Care Decision Aid Among Patients And Physicians_Matlock

A NA study of Palliative Care and Decision Making, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01190488: Completed NA study of Palliative Care and Decision Making, sponsored by University of Colorado, Denver.

NCT01190488 is a NA study of Palliative Care and Decision Making that has completed, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 1,410-participant average among 18 other Palliative Care trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01190488, a NA study of Palliative Care and Decision Making, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The investigators propose an evaluation of an end of life patient decision aid (EOL-PtDA) developed by the Foundation for Informed Medical Decision Making using the RE-AIM (Reach Effectiveness, Adoption, Implementation, and Maintenance) framework. To evaluate the Reach and Effectiveness, the investigators propose a pilot randomized clinical trial of the EOL-PtDA among patients on the inpatient palliative care service at University Hospital in Colorado. To evaluate barriers and facilitators of Adoption, Implementation, and Maintenance of the EOL-PtDA, we propose focus groups of non-palliative care physicians as we perceive these physicians to be the largest barrier to ultimate adoption of the EOL-PtDA. Additionally we propose a focus group of the palliative care physicians who participated in the implementation of this decision guide study to evaluate the feasibility of conducting a randomized control trial within a pall. care service and to evaluate the acceptability of this decision aid as it was implemented. The investigators also propose to conduct focus groups of normal, healthy clinic patients to determine the acceptability among that population. The End-of-Life decision aid is different from other decision aids. From the vantage point of decision quality, a major difference is that its primary focus is on helping patients clarify their values rather than gain knowledge. The results from this study will provide critical preliminary data to inform a randomized clinical trial and/or widespread implementation of the EOL-PtDA. Specific Aims/Research question(s):Aim 1: To determine the Reach and Effectiveness of an end-of-life patient decision aid by conducting a pilot randomized clinical trial in an inpatient palliative care service. Aim 2: To determine physicians' attitudes towards the end-of-life patient decision aid and to gain insights into potential barriers and facilitators to Adoption, Implementation, and Maintenance by conducting a qualitative study of non

Primary Outcome

We will follow enrolled patients for the duration of the study and examine the following metrics: days in the ICU, place of death, resuscitation status, chemotherapy, feeding tube, discharge disposition and re-hospitalization status. Patients in both groups will be asked to complete a brief quantitative survey.

Interventions

  • BEHAVIORAL Active Comparator
  • BEHAVIORAL End-of-Life / Advanced Care Decision Aid

Study Locations (1)

Colorado

  • University of Colorado Hospital - Aurora

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-11
Est. Completion 2011-11
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT01190488 record still lists

NCT01190488 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,410-participant average among 18 other Palliative Care trials with a reported enrollment target (91% lower).

The record links to 5 conditions, with Palliative Care appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator is the first listed.

NCT01190488 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01190488 about?

NCT01190488 is a clinical study titled "Feasibility Of An Advanced Care Decision Aid Among Patients And Physicians_Matlock". The investigators propose an evaluation of an end of life patient decision aid (EOL-PtDA) developed by the Foundation for Informed Medical Decision Making using the RE-AIM (Reach Effectiveness, Adoption, Implementation, and Maintenance) framework. To evaluate the Reach and Effectiveness, the investi...

What is the current status of trial NCT01190488?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2009-11. Estimated completion is 2011-11.

What conditions does trial NCT01190488 study?

This clinical trial studies the following conditions: Palliative Care, Decision Making, Decision Support Systems, Clinical, Hospices, Decision Support Techniques.

What interventions are being tested in trial NCT01190488?

The interventions under investigation include: Active Comparator (BEHAVIORAL), End-of-Life / Advanced Care Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT01190488?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01190488 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Palliative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01190488's enrollment target sits among peer trials

120 10th of 18 higher than 9 of 18 other Palliative Care trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Palliative Care trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01190488, the US trial registry maintained by the National Library of Medicine. NCT01190488 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.